计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| N102062-1g |
1g |
现货 ![]() |
| |
| N102062-5g |
5g |
现货 ![]() |
| |
| N102062-25g |
25g |
现货 ![]() |
| |
| N102062-100g |
100g |
现货 ![]() |
| |
| N102062-500g |
500g |
现货 ![]() |
|
| 别名 | N-乙基-邻巴豆酰甲酰苯胺 |
|---|---|
| 英文别名 | CCG-39402 | NSC 758951 | component of Eurax (Salt/Mix) | Pharmakon1600-01505271 | D70888 | MLS002222307 | 3-12-00-01856 (Beilstein Handbook Reference) | AKOS015892746 | Euraxil | HMS1570P04 | HMS2093O12 | SR-01000759366-4 | HMS2090A10 | Crotamiton, Britis |
| 规格或纯度 | Moligand™, ≥97%(predominantly trans) |
| 英文名称 | Crotamiton |
| 生化机理 | 杀菌和止痒剂。对the螨有毒。 |
| 应用 | N-Ethyl-o-crotonotoluidide ( Crotamiton) was used to study the photocatalytic decomposition of crotamiton in aqueous solution using TiO2 N-Ethyl-o-crotonotoluidide (Crotamiton) was used to treat scabies and various pruritic dermatoses. |
| 储存温度 | 充氩 |
| 运输条件 | 常规运输 |
| 作用类型 | 抑制剂 |
| 作用机制 | TRPV4 抑制剂 |
| 备注 | 如果有可能,您尽量在使用的当天配置溶液,并在当天使用完它。但是,如果您需要预先配制储备溶液,我们建议您将溶液等份保存在-20°C的密封小瓶中。通常,它们最多可以使用一个月。在使用前和打开样品瓶之前,我们建议您让您的产品在室温下平衡至少1小时。需要更多关于溶解度,用法和处理的建议吗?请访问我们的常见问题(FAQ)页面以获取更多详细信息。 |
| 产品介绍 |
N-Ethyl-o-crotonotoluidide ( Crotamiton) was used to study the photocatalytic decomposition of crotamiton in aqueous solution using TiO2 N-Ethyl-o-crotonotoluidide (Crotamiton) was used to treat scabies and various pruritic dermatoses. |
| 纯度 | ≥97%(predominantly trans) |
| ALogP | 2.8 |
|---|
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| PubChem SID | 488191073 |
|---|---|
| EC号 | 207-596-3 |
| 分子类型 | 小分子 |
| IIUPAC Name | (E)-N-ethyl-N-(2-methylphenyl)but-2-enamide |
| INCHI | 1S/C13H17NO/c1-4-8-13(15)14(5-2)12-10-7-6-9-11(12)3/h4,6-10H,5H2,1-3H3/b8-4+ |
| InChi Key | DNTGGZPQPQTDQF-XBXARRHUSA-N |
| Smiles | CCN(C1=CC=CC=C1C)C(=O)C=CC |
| Isomeric SMILES | CCN(C1=CC=CC=C1C)C(=O)/C=C/C |
| 分子量 | 203.28 |
| Reaxy-Rn | 9759779 |
| Reaxys-RN link address | https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=9759779&ln= |
| 密度 | 0.987 |
|---|---|
| 敏感性 | 对空气敏感 |
| 折光率 | 1.54 |
| 闪点(℉) | 235.4 °F |
| 闪点(℃) | 113 °C |
| 沸点 | 153-155°C/13mmHg |
| 分子量 | 203.280 g/mol |
| XLogP3 | 2.800 |
| 氢键供体数Hydrogen Bond Donor Count | 0 |
| 氢键受体数Hydrogen Bond Acceptor Count | 1 |
| 可旋转键计数Rotatable Bond Count | 3 |
| 精确质量Exact Mass | 203.131 Da |
| 单同位素质量Monoisotopic Mass | 203.131 Da |
| 拓扑极表面积Topological Polar Surface Area | 20.300 Ų |
| 重原子数Heavy Atom Count | 15 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 235.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 0 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 1 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 1 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |
| 象形图 | GHS07 |
|---|---|
| 信号词 | 警告 |
| 危险声明 |
H302: 吞食有害 H315: 引起皮肤刺激 H317: 可能引起皮肤过敏反应 H319: 引起严重眼睛刺激 |
| 预防措施声明 |
P261: 避免吸入灰尘/烟雾/气体/雾/蒸汽/喷雾 P264: 处理后要彻底洗手。 P270: 使用本产品时,请勿进食、饮水或吸烟。 P272: 被污染的工作服不允许离开工作场所 P280: 戴防护手套/穿防护服/戴防护眼罩/戴防护面具。 P321: 特殊处理(请参阅此标签上的...)。 P330: 漱口 P302+P352: 如皮肤沾染:用水充分清洗。 P305+P351+P338: 如进入眼睛:用水小心冲洗几分钟。如戴隐形眼镜并可方便地取出,取出隐形眼镜。继续冲洗。 P333+P313: 如发生皮肤刺激或皮疹:求医/就诊。 P362+P364: 脱掉沾污的衣服,清洗后方可重新使用。 P501: 将内容物/容器处理到。。。 P264+P265: 处理后彻底洗手[和…]。不要触摸眼睛。 P301+P317: 如果被吞咽:请寻求医疗帮助。 P337+P317: 如果眼睛刺激持续:寻求医疗帮助。 P332+P317: 如果出现皮肤刺激:请寻求医疗帮助。 |
| WGK Germany | 3 |
| RTECS | GQ7000000 |
| 个人防护装备 | dust mask type N95 (US),Eyeshields,Faceshields,Gloves |
通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!
| 批号(Lot Number) | 证书类型 | 货号 |
|---|---|---|
| 分析证书 | N102062 | |
| 分析证书 | N102062 | |
| 分析证书 | N102062 | |
| 分析证书 | N102062 | |
| 分析证书 | N102062 | |
| 分析证书 | N102062 | |
| 分析证书 | N102062 | |
| 分析证书 | N102062 | |
| 分析证书 | N102062 | |
| 分析证书 | N102062 | |
| 分析证书 | N102062 | |
| 分析证书 | N102062 | |
| 分析证书 | N102062 |
| 1. Kittaka H, Yamanoi Y, Tominaga M. (2017) Transient receptor potential vanilloid 4 (TRPV4) channel as a target of crotamiton and its bimodal effects.. Pflugers Arch, 469 (10): (1313-1323). [PMID:28612138] |
| 2. F Forton,B Seys,J L Marchal,A M Song. (1998-05-15) Demodex folliculorum and topical treatment: acaricidal action evaluated by standardized skin surface biopsy.. The British journal of dermatology, 138 ((3)): (461-466). [PMID:9580800] |
| 3. S M Hwang,M S Yoo,S K Ahn,E H Choi. (1998-09-10) Demodecidosis manifested on the external genitalia.. International journal of dermatology, 37 ((8)): (634-636). [PMID:9732019] |
| 4. P D Morgan-Glenn. (2001-09-05) Scabies.. Pediatrics in review, 22 ((9)): (322-323). [PMID:11533383] |
| 5. S A Holme,C M Mills. (2001-10-13) Crotamiton and narrow-band UVB phototherapy: novel approaches to alleviate pruritus of breast carcinoma skin infiltration.. Journal of pain and symptom management, 22 ((4)): (803-805). [PMID:11596612] |
| 6. M Bigby. (2002-07-10) A systematic review of the treatment of scabies.. Archives of dermatology, 136 ((3)): (387-389). [PMID:12102094] |
| 7. Godfrey Walker,Paul Johnstone. (2002-09-17) Scabies.. Clinical evidence, ((7)(7)): (1543-1548). [PMID:12230770] |
| 8. Noriko Ohtaki,Hiroko Taniguchi,Hiroshi Ohtomo. (2003-05-30) Oral ivermectin treatment in two cases of scabies: effective in crusted scabies induced by corticosteroid but ineffective in nail scabies.. The Journal of dermatology, 30 ((5)): (411-416). [PMID:12773808] |
| 9. Naoki Oiso,Kazuyoshi Fukai,Masamitsu Ishii. (2004-03-05) Triple allergic contact sensitivities due to ferbinac, crotamiton and diisopropanolamine.. Contact dermatitis, 49 ((5)): (261-263). [PMID:14996052] |
| 10. H Hara,T Masuda,A Yokoyama,H Asaki,T Okada,H Suzuki. (2004-03-05) Allergic contact dermatitis due to crotamiton.. Contact dermatitis, 49 ((4)): (219-219). [PMID:14996078] |
| 11. Habib Ansarin,Mir Hadi Aziz Jalali,Shadi Mazloomi,Razieh Soltani-Arabshahi,Roya Setarehshenas. (2006-04-28) Scabies presenting with bullous pemphigoid-like lesions.. Dermatology online journal, 12 ((1)): (19-19). [PMID:16638387] |
| 12. M COUPERUS. (1949-07-01) The use of N-ethyl-o-crotonotoluidide in the treatment of scabies and various pruritic dermatoses.. The Journal of investigative dermatology, 13 ((1)): (35-42). [PMID:18133471] |
| 13. N Nakada,M Yasojima,Y Okayasu,K Komori,Y Suzuki. (2010-04-08) Mass balance analysis of triclosan, diethyltoluamide, crotamiton and carbamazepine in sewage treatment plants.. Water science and technology : a journal of the International Association on Water Pollution Research, 61 ((7)): (1739-1747). [PMID:20371932] |
| 14. A Parodi,F Drago,S Paolino,E Cozzani,R Gallo. (2011-09-13) [Treatment of rosacea].. Annales de dermatologie et de venereologie, 138 Suppl 2 (S158-S162). [PMID:21907876] |
| 15. Rika Sekine,Takahiro Satoh,Ayumi Takaoka,Kazumi Saeki,Hiroo Yokozeki. (2012-03-03) Anti pruritic effects of topical crotamiton, capsaicin, and a corticosteroid on pruritogen-induced scratching behavior.. Experimental dermatology, 21 ((3)): (201-204). [PMID:22379965] |
| 16. Shuji Fukahori,Taku Fujiwara,Ryusei Ito,Naoyuki Funamizu. (2012-05-15) Photocatalytic decomposition of crotamiton over aqueous TiO(2) suspensions: determination of intermediates and the reaction pathway.. Chemosphere, 89 ((3)): (213-220). [PMID:22578794] |
| 17. G J Walker,P W Johnstone. (2000-05-05) Interventions for treating scabies.. The Cochrane database of systematic reviews, (2) ((2)): (CD000320-CD000320). [PMID:10796527] |
| 18. Kyoung-Jin Kim,Kyung-Hyun Roh,Jee-Ho Choi,Kyung-Jeh Sung,Kee-Chan Moon,Jai-Kyoung Koh. (2002-10-18) Scabies incognito presenting as urticaria pigmentosa in an infant.. Pediatric dermatology, 19 ((5)): (409-411). [PMID:12383096] |
| 19. Maria Wesołowska,Wojciech Baran,Jacek Szepietowski,Larysa Hirschberg,Stanisław Jankowski. (2006-08-18) [Demodicidosis in humans as a current problem in dermatology].. Wiadomosci parazytologiczne, 51 ((3)): (253-256). [PMID:16913532] |
| 20. E Dika,A Tosti,M Goldovsky,R Wester,H I Maibach. (2006-09-19) Percutaneous absorption of crotamiton in man following single and multiple dosing.. Cutaneous and ocular toxicology, 25 ((3)): (211-216). [PMID:16980246] |
| 21. Ulrich R Hengge,Bart J Currie,Gerold Jäger,Omar Lupi,Robert A Schwartz. (2006-11-25) Scabies: a ubiquitous neglected skin disease.. The Lancet. Infectious diseases, 6 ((12)): (769-779). [PMID:17123897] |
| 22. Yuji Higaki. (2007-03-08) [Treatment for scabies].. Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics, 44 ((1)): (126-126). [PMID:17342823] |
| 23. Ahmed M Al-Arfaj,Gary R Mullen,Rafiaa Rashad,Ahmed Abdel-Hameed,Barry M OConnor,Ibrahim S Alkhalife,Roland R Dute. (2007-05-10) A human case of otoacariasis involving a histiostomatid mite (Acari: Histiostomatidae).. The American journal of tropical medicine and hygiene, 76 ((5)): (967-971). [PMID:17488924] |
| 24. M Royer,C-M Latre,C Paul,J Mazereeuw-Hautier. (2008-12-17) [Infantile scabies].. Annales de dermatologie et de venereologie, 135 ((12)): (876-881). [PMID:19084706] |
| 25. Maren Kahle,Ignaz J Buerge,Markus D Müller,Thomas Poiger. (2009-08-18) Hydrophilic anthropogenic markers for quantification of wastewater contamination in ground- and surface waters.. Environmental toxicology and chemistry, 28 ((12)): (2528-2536). [PMID:19681643] |
| 26. Keisuke Kuroda,Michio Murakami,Kumiko Oguma,Yuki Muramatsu,Hideshige Takada,Satoshi Takizawa. (2011-12-24) Assessment of groundwater pollution in Tokyo using PPCPs as sewage markers.. Environmental science & technology, 46 ((3)): (1455-1464). [PMID:22191375] |
| 27. Xixi Chen, Wanyi Fu, Yulong Yang, Yanjun Li, Kai Yang, Xuanbo Xu, Xihui Zhang. (2023) Essential role of atomic H* in activating hydrogen peroxide to produce singlet oxygen for emerging organic contaminants degradation. Journal of Environmental Chemical Engineering, 11 (109442). [10.1016/j.jece.2023.109442] |